Compare Multikarya Asia Pasifik Raya Tbk. (MKAP) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multikarya Asia Pasifik Raya Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Multikarya Asia Pasifik Raya Tbk. trades at Rp1,115 (market cap 3.62T, 38K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Multikarya Asia Pasifik Raya Tbk. is far larger — about 34.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MKAP | SCPI | |
|---|---|---|
Market Cap | 3.62T | 104.4B |
Volume | 38K | — |
Lot | 380 | — |
Turnover | 42.24M | — |
Average Price | 1,111.46 | — |
Value | 42.24M | — |
Indicative Equilibrium Price | 1,115 | — |
Indicative Equilibrium Volume | 300 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multikarya Asia Pasifik Raya Tbk.
PT Multikarya Asia Pasifik Raya Tbk (the Company) was established on May 16, 2002 in Jakarta, Indonesia under the name of PT Mudking Asia Pasifik Raya, herein after, based on Notarial Deed No. 43 of Yunardi, S.H. The Company started its commercial operations in 2002.
Read more on MKAP →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
